The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Immunogenetic Mechanisms Driving Norovirus GII.4 Antigenic Variation
Open accessAbstract
Noroviruses are the principal cause of epidemic gastroenteritis worldwide with GII.4 strains accounting for 80% of infections. The major capsid protein of GII.4 strains is evolving rapidly, resulting in new epidemic strains with altered antigenic potentials. To test if antigenic drift may contribute to GII.4 persistence, human memory B cells were immortalized and the resulting human monoclonal antibodies (mAbs) characterized for reactivity to a panel of time-ordered GII.4 virus-like particles (VLPs). Reflecting the complex exposure history of the volunteer, human anti-GII.4 mAbs grouped into three VLP reactivity patterns; ancestral (1987-1997), contemporary (2004-2009), and broad (1987-2009). NVB 114 reacted exclusively to the earliest GII.4 VLPs by EIA and blockade. NVB 97 specifically bound and blocked only contemporary GII.4 VLPs, while NBV 111 and 43.9 exclusively reacted with and blocked variants of the GII.4.2006 Minerva strain. Three mAbs had broad GII.4 reactivity. Two, NVB 37.10 and 61.3, also detected other genogroup II VLPs by EIA but did not block any VLP interactions with carbohydrate ligands. NVB 71.4 cross-neutralized the panel of time-ordered GII.4 VLPs, as measured by VLP-carbohydrate blockade assays. Using mutant VLPs designed to alter predicted antigenic epitopes, two evolving, GII.4-specific, blockade epitopes were mapped. Amino acids 294-298 and 368-372 were required for binding NVB 114, 111 and 43.9 mAbs. Amino acids 393-395 were essential for binding NVB 97, supporting earlier correlations between antibody blockade escape and carbohydrate binding variation. These data inform VLP vaccine design, provide a strategy for expanding the cross-blockade potential of chimeric VLP vaccines, and identify an antibody with broadly neutralizing therapeutic potential for the treatment of human disease. Moreover, these data support the hypothesis that GII.4 norovirus evolution is heavily influenced by antigenic variation of neutralizing epitopes and consequently, antibody-driven receptor switching; thus, protective herd immunity is a driving force in norovirus molecular evolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple sequence alignment with the Clustal series of programs
Chenna, R. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg500 · Cited by 4,875
Human susceptibility and resistance to Norwalk virus infection
Lindesmith, L., Moe, C., Marionneau, S., Ruvoen, N., Jiang, X., Lindblad, L., Stewart, P., LePendu, J., & Baric, R. (2003) · Nature Medicine · doi:10.1038/nm860 · Cited by 1,119
Self-citationNorovirus classification and proposed strain nomenclature
Zheng, D.-P., Ando, T., Fankhauser, R. L., Beard, R. S., Glass, R. I., & Monroe, S. S. (2006) · Virology · doi:10.1016/j.virol.2005.11.015 · Cited by 1,093
Development trends for human monoclonal antibody therapeutics
Nelson, A. L., Dhimolea, E., & Reichert, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3229 · Cited by 1,026
Glass, R. I., Parashar, U. D., & Estes, M. K. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804575 · Cited by 1,010
Systematic Literature Review of Role of Noroviruses in Sporadic Gastroenteritis
Patel, M. M., Widdowson, M.-A., Glass, R. I., Akazawa, K., Vinjé, J., & Parashar, U. D. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1408.071114 · Cited by 953
X-ray Crystallographic Structure of the Norwalk Virus Capsid
Prasad, B. V. V., Hardy, M. E., Dokland, T., Bella, J., Rossmann, M. G., & Estes, M. K. (1999) · Science · doi:10.1126/science.286.5438.287 · Cited by 946
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697
Self-citationMechanisms of GII.4 Norovirus Persistence in Human Populations
Lindesmith, L. C., Donaldson, E. F., LoBue, A. D., Cannon, J. L., Zheng, D.-P., Vinje, J., & Baric, R. S. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050031 · Cited by 573
Self-citationIncrease in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant
Lopman, B., Vennema, H., Kohli, E., Pothier, P., Sanchez, A., Negredo, A., Buesa, J., Schreier, E., Gray, J., Gallimore, C., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15641-9 · Cited by 518
Norovirus Vaccine against Experimental Human Norwalk Virus Illness
Atmar, R. L., Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., Estes, M. K., Graham, D. Y., Opekun, A. R., Richardson, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1101245 · Cited by 490
Clinical Immunity in Acute Gastroenteritis Caused by Norwalk Agent
Parrino, T. A., Schreiber, D. S., Trier, J. S., Kapikian, A. Z., & Blacklow, N. R. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707142970204 · Cited by 478
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors
Yu, X., Tsibane, T., McGraw, P. A., House, F. S., Keefer, C. J., Hicar, M. D., Tumpey, T. M., Pappas, C., Perrone, L. A., Martinez, O., et al. (2008) · Nature · doi:10.1038/nature07231 · Cited by 452
Whittle, J. R. R., Zhang, R., Khurana, S., King, L. R., Manischewitz, J., Golding, H., Dormitzer, P. R., Haynes, B. F., Walter, E. B., Moody, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111497108 · Cited by 439
Updated norovirus outbreak management and disease prevention guidelines.
Gregoricus, N., Hall, A. J., Lopman, B. A., et al. (2011) · PubMed · Cited by 427
Epochal Evolution of GGII.4 Norovirus Capsid Proteins from 1995 to 2006
Siebenga, J. J., Vennema, H., Renckens, B., de Bruin, E., van der Veer, B., Siezen, R. J., & Koopmans, M. (2007) · Journal of Virology · doi:10.1128/jvi.00674-07 · Cited by 389
Passive immunity in prevention and treatment of infectious diseases
Keller, M. A., & Stiehm, E. R. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.602 · Cited by 388
Structural Basis for the Recognition of Blood Group Trisaccharides by Norovirus
Cao, S., Lou, Z., Tan, M., Chen, Y., Liu, Y., Zhang, Z., Zhang, X. C., Jiang, X., Li, X., & Rao, Z. (2007) · Journal of Virology · doi:10.1128/jvi.00219-07 · Cited by 387
Bull, R. A., Tu, E. T. V., McIver, C. J., Rawlinson, W. D., & White, P. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.327-333.2006 · Cited by 344
Norovirus disease: changing epidemiology and host susceptibility factors
Hutson, A. M., Atmar, R. L., & Estes, M. K. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.04.005 · Cited by 314
Cellular and Humoral Immunity following Snow Mountain Virus Challenge
Lindesmith, L. C., Moe, C. L., Pendu, J. L., Frelinger, J. A., Treanor, J. J., & Baric, R. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2900-2909.2005 · Cited by 302
Self-citationRapid Evolution of Pandemic Noroviruses of the GII.4 Lineage
Bull, R. A., Eden, J.-S., Rawlinson, W. D., & White, P. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000831 · Cited by 301
Harrington, P. R., Lindesmith, L., Yount, B., Moe, C. L., & Baric, R. S. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.12335-12343.2002 · Cited by 290
Self-citationWiddowson, M., Cramer, E. H., Hadley, L., Bresee, J. S., Beard, R. S., Bulens, S. N., Charles, M., Chege, W., Isakbaeva, E., Wright, J. G., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/420888 · Cited by 283
Pierson, T. C., Fremont, D. H., Kuhn, R. J., & Diamond, M. S. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.08.004 · Cited by 281
Serological Correlate of Protection against Norovirus‐Induced Gastroenteritis
Reeck, A., Kavanagh, O., Estes, M. K., Opekun, A. R., Gilger, M. A., Graham, D. Y., & Atmar, R. L. (2010) · The Journal of Infectious Diseases · doi:10.1086/656364 · Cited by 278
Evolutionary Dynamics of GII.4 Noroviruses over a 34-Year Period
Bok, K., Abente, E. J., Realpe-Quintero, M., Mitra, T., Sosnovtsev, S. V., Kapikian, A. Z., & Green, K. Y. (2009) · Journal of Virology · doi:10.1128/jvi.00864-09 · Cited by 278
Choi, J.-M., Hutson, A. M., Estes, M. K., & Prasad, B. V. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803275105 · Cited by 268
Norwalk Virus-Like Particle Hemagglutination by Binding to H Histo-Blood Group Antigens
Hutson, A. M., Atmar, R. L., Marcus, D. M., & Estes, M. K. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.405-415.2003 · Cited by 262
Tan, M., Hegde, R. S., & Jiang, X. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6233-6242.2004 · Cited by 256
Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations
Donaldson, E. F., Lindesmith, L. C., Lobue, A. D., & Baric, R. S. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00680.x · Cited by 255
Self-citationNovel Surveillance Network for Norovirus Gastroenteritis Outbreaks, United States
Vega, E. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1708.101837 · Cited by 237
Vinjé, J., Altena, S. A., & Koopmans, M. P. G. (1997) · The Journal of Infectious Diseases · doi:10.1086/517325 · Cited by 231
El‐Kamary, S. S., Pasetti, M. F., Mendelman, P. M., Frey, S. E., Bernstein, D. I., Treanor, J. J., Ferreira, J., Chen, W. H., Sublett, R., Richardson, C., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/657087 · Cited by 226
Tan, M., & Jiang, X. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14017-14030.2005 · Cited by 226
Chimpanzees as an animal model for human norovirus infection and vaccine development
Bok, K., Parra, G. I., Mitra, T., Abente, E., Shaver, C. K., Boon, D., Engle, R., Yu, C., Kapikian, A. Z., Sosnovtsev, S. V., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014577107 · Cited by 215
Noroviruses everywhere: has something changed?
Estes, M. K., Prasad, B. V., & Atmar, R. L. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000244053.69253.3d · Cited by 210
Deaths from Norovirus among the Elderly, England and Wales
Harris, J. P., Edmunds, W. J., Pebody, R., Brown, D. W., & Lopman, B. A. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1410.080188 · Cited by 204
Updated norovirus outbreak management and disease prevention guidelines.
(2011) · PubMed · Cited by 199
Outbreak Management and Implications of a Nosocomial Norovirus Outbreak
Johnston, C. P., Qiu, H., Ticehurst, J. R., Dickson, C., Rosenbaum, P., Lawson, P., Stokes, A. B., Lowenstein, C. J., Kaminsky, M., Cosgrove, S. E., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/520666 · Cited by 186
Chen, R., Neill, J. D., Estes, M. K., & Prasad, B. V. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600421103 · Cited by 180
Noel, J. S., Ando, T., Leite, J. P. G., Green, K. Y., Dingle, K. E., Estes, M. K., Seto, Y., Monroe, S. S., & Glass, R. I. (1997) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199712)53:4<372::aid-jmv10>3.0.co;2-h · Cited by 179
Molecular Epidemiology of Human Enteric Caliciviruses in The Netherlands
Koopmans, M., Vinjé, J., de Wit, M., Leenen, I., van der Poel, W., & van Duynhoven, Y. (2000) · The Journal of Infectious Diseases · doi:10.1086/315573 · Cited by 179
Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization
Nelson, S., Jost, C. A., Xu, Q., Ess, J., Martin, J. E., Oliphant, T., Whitehead, S. S., Durbin, A. P., Graham, B. S., Diamond, M., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000060 · Cited by 173
Monoclonal antibody-based therapies for microbial diseases
Saylor, C., Dadachova, E., & Casadevall, A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.09.105 · Cited by 172
de Rougemont, A., Ruvoën‐Clouet, N., Simon, B., Estienney, M., Élie-Caille, C., Aho, S., Pothier, P., LePendu, J., Boireau, W., & Belliot, G. (2011) · Journal of Virology · doi:10.1128/jvi.02077-10 · Cited by 168
Noroviruses: The leading cause of gastroenteritis worldwide.
Koo, H. L., Ajami, N. J., Atmar, R. L., & DuPont, H. L. (2010) · PubMed · Cited by 164
Norovirus GII.4 Strain Antigenic Variation
Lindesmith, L. C., Donaldson, E. F., & Baric, R. S. (2011) · Journal of Virology · doi:10.1128/jvi.01364-10 · Cited by 164
Self-citationNoroviral P particle: Structure, function and applications in virus–host interaction
Tan, M., Fang, P., Chachiyo, T., Xia, M., Huang, P., Fang, Z., Jiang, W., & Jiang, X. (2008) · Virology · doi:10.1016/j.virol.2008.08.047 · Cited by 160
Debbink, K., Donaldson, E. F., Lindesmith, L. C., & Baric, R. S. (2012) · Journal of Virology · doi:10.1128/jvi.06189-11 · Cited by 159
Self-citationNorovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production
Tan, M., Huang, P., Xia, M., Fang, P., Zhong, W., McNeal, M., Wei, C., Jiang, W., & Jiang, X. (2010) · Journal of Virology · doi:10.1128/jvi.01835-10 · Cited by 159
Shanker, S., Choi, J.-M., Sankaran, B., Atmar, R. L., Estes, M. K., & Prasad, B. V. V. (2011) · Journal of Virology · doi:10.1128/jvi.00848-11 · Cited by 158
Heterotypic Humoral and Cellular Immune Responses following Norwalk Virus Infection
Lindesmith, L. C., Donaldson, E., León, J. S., Moe, C. L., Frelinger, J. A., Johnston, R. E., Weber, D. J., & Baric, R. S. (2009) · Journal of Virology · doi:10.1128/jvi.02179-09 · Cited by 157
Self-citationSiebenga, J. J., Lemey, P., Pond, S. L. K., Rambaut, A., Vennema, H., & Koopmans, M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000884 · Cited by 148
Allen, D. J., Gray, J. J., Gallimore, C. I., Xerry, J., & Iturriza‐Gómara, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001485 · Cited by 140
Monoclonal Antibody-Based Antigenic Mapping of Norovirus GII.4-2002
Lindesmith, L. C., Debbink, K. M., Swanstrom, J., Vinjé, J., Costantini, V., Baric, R. S., & Donaldson, E. (2011) · Journal of Virology · doi:10.1128/jvi.06200-11 · Cited by 133
Self-citationKaufmann, B., Vogt, M. R., Goudsmit, J., Holdaway, H. A., Aksyuk, A. A., Chipman, P. R., Kuhn, R. J., Diamond, M., & Rossmann, M. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011036107 · Cited by 128
Lochridge, V. P., Jutila, K. L., Graff, J. W., & Hardy, M. E. (2005) · Journal of General Virology · doi:10.1099/vir.0.81134-0 · Cited by 121
Herd Immunity to GII.4 Noroviruses Is Supported by Outbreak Patient Sera
Cannon, J. L., Lindesmith, L. C., Donaldson, E., Saxe, L., Baric, R. S., & Vinjé, J. (2009) · Journal of Virology · doi:10.1128/jvi.02518-08 · Cited by 111
Self-citationTan, M., Zhong, W., Song, D., Thornton, S. A., & Jiang, X. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20228 · Cited by 101
Baric, R. S., Yount, B. L., Lindesmith, L. C., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.3023-3030.2002 · Cited by 100
Self-citationA comparison of immunogenicity of norovirus GII‐4 virus‐like particles and P‐particles
Tamminen, K., Huhti, L., Koho, T., Lappalainen, S., Hytönen, V. P., Vesikari, T., & Blazevic, V. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03516.x · Cited by 96
Tan, M., Xia, M., Cao, S., Huang, P., Farkas, T., Meller, J., Hegde, R. S., Li, X., Rao, Z., & Jiang, X. (2008) · Virology · doi:10.1016/j.virol.2008.06.041 · Cited by 87
Rockx, B., Donaldson, E., Frieman, M. B., Sheahan, T. P., Corti, D., Lanzavecchia, A., & Baric, R. S. (2010) · The Journal of Infectious Diseases · doi:10.1086/651022 · Cited by 84
Self-citationAllen, D. J., Noad, R. J., Samuel, D., Gray, J. J., Roy, P., & Iturriza‐Gómara, M. (2009) · Virology Journal · doi:10.1186/1743-422x-6-150 · Cited by 81
Czakó, R., Atmar, R. L., Opekun, A. R., Gilger, M. A., Graham, D. Y., & Estes, M. K. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05592-11 · Cited by 61
Tan, M., Fang, P., Xia, M., Chachiyo, T., Jiang, W., & Jiang, X. (2010) · Virology · doi:10.1016/j.virol.2010.11.017 · Cited by 58
Bereszczak, J. Z., Barbu, I., Tan, M., Xia, M., Jiang, X., van Duijn, E., & Heck, A. J. R. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.01.005 · Cited by 53
Siebenga, J. J., Kroneman, A., Vennema, H., Duizer, E., & Koopmans, M. (2008) · Eurosurveillance · doi:10.2807/ese.13.02.08009-en · Cited by 53
Norovirus activity--United States, 2006-2007.
(2007) · PubMed · Cited by 49
Zhu, Z., Dimitrov, A. S., Chakraborti, S., Dimitrova, D., Xiao, X., Broder, C. C., & Dimitrov, D. S. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.1.57 · Cited by 31
Cited by
Genetic Analysis of Human Norovirus Strains in Japan in 2016–2017
Nagasawa, K., Matsushima, Y., Motoya, T., Mizukoshi, F., Ueki, Y., Sakon, N., Murakami, K., Shimizu, T., Okabe, N., Nagata, N., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00001 · Cited by 1,257
Advances in Laboratory Methods for Detection and Typing of Norovirus
Vinjé, J. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01535-14 · Cited by 750
Robilotti, E., Deresinski, S., & Pinsky, B. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00075-14 · Cited by 589
Comprehensive Review of Human Sapoviruses
Oka, T., Wang, Q., Katayama, K., & Saif, L. J. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00011-14 · Cited by 353
Bernstein, D. I., Atmar, R. L., Lyon, G. M., Treanor, J. J., Chen, W. H., Jiang, X., Vinje, J., Gregoricus, N., Frenck, R. W., Moe, C. L., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu497 · Cited by 276
Metadata
- Authors
- Lindesmith, L. C., Beltramello, M., Donaldson, E. F., Corti, D., Swanstrom, J., Debbink, K., Lanzavecchia, A., & Baric, R. S.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-17
- Volume
- 8
- Issue
- 5
- Pages
- e1002705
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W1993086912
- Cited by
- 266
- References
- 71
- FWCI
- 20.24
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.